According to our (Global Info Research) latest study, the global Cardiac Resynchronization Therapy Equipment market size was valued at US$ 12200 million in 2024 and is forecast to a readjusted size of USD 15000 million by 2031 with a CAGR of 3.0% during review period.
Cardiac Resynchronization Therapy (CRT) equipment is a medical technology used to treat certain heart conditions that cause heart failure and abnormal heart rhythms. CRT aims to improve the coordination of the heart"s chambers, specifically the ventricles, to enhance its pumping efficiency and overall function.
Cardiac Resynchronization Therapy (CRT) equipment is an important and growing segment within the medical devices industry, catering to patients with heart failure and specific electrical conduction abnormalities. CRT devices, which are essentially biventricular pacemakers, play a crucial role in improving cardiac function by synchronizing the contractions of the heart"s ventricles. The CRT equipment market has witnessed steady growth over the years due to an increasing prevalence of heart failure and a growing elderly population. As more patients are diagnosed with heart failure and specific indications for CRT, the demand for these devices has been on the rise. North America, comprising the United States and Canada, has been a leading market for CRT equipment. The region has well-established healthcare systems, advanced medical technology adoption, and a high prevalence of heart failure cases. Favorable reimbursement policies have also contributed to the robust CRT equipment market in this region.
This report is a detailed and comprehensive analysis for global Cardiac Resynchronization Therapy Equipment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cardiac Resynchronization Therapy Equipment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cardiac Resynchronization Therapy Equipment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cardiac Resynchronization Therapy Equipment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Cardiac Resynchronization Therapy Equipment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cardiac Resynchronization Therapy Equipment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cardiac Resynchronization Therapy Equipment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Abbott, MicroPort, Biotronik, Livanova, Lepu Medical, Nihon Kohden, Pacetronix, Asahi Kasei, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cardiac Resynchronization Therapy Equipment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
CRT Defibrillator
CRT Pacemaker
Market segment by Application
Hospital
Cardiac Center
Others
Major players covered
Medtronic
Boston Scientific
Abbott
MicroPort
Biotronik
Livanova
Lepu Medical
Nihon Kohden
Pacetronix
Asahi Kasei
St. Jude Medical
Sorin Group
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cardiac Resynchronization Therapy Equipment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cardiac Resynchronization Therapy Equipment, with price, sales quantity, revenue, and global market share of Cardiac Resynchronization Therapy Equipment from 2020 to 2025.
Chapter 3, the Cardiac Resynchronization Therapy Equipment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cardiac Resynchronization Therapy Equipment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cardiac Resynchronization Therapy Equipment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiac Resynchronization Therapy Equipment.
Chapter 14 and 15, to describe Cardiac Resynchronization Therapy Equipment sales channel, distributors, customers, research findings and conclusion.
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Cardiac Resynchronization Therapy Equipment Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 CRT Defibrillator
- 1.3.3 CRT Pacemaker
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Cardiac Resynchronization Therapy Equipment Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Cardiac Center
- 1.4.4 Others
- 1.5 Global Cardiac Resynchronization Therapy Equipment Market Size & Forecast
- 1.5.1 Global Cardiac Resynchronization Therapy Equipment Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Cardiac Resynchronization Therapy Equipment Sales Quantity (2020-2031)
- 1.5.3 Global Cardiac Resynchronization Therapy Equipment Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Medtronic
- 2.1.1 Medtronic Details
- 2.1.2 Medtronic Major Business
- 2.1.3 Medtronic Cardiac Resynchronization Therapy Equipment Product and Services
- 2.1.4 Medtronic Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Medtronic Recent Developments/Updates
- 2.2 Boston Scientific
- 2.2.1 Boston Scientific Details
- 2.2.2 Boston Scientific Major Business
- 2.2.3 Boston Scientific Cardiac Resynchronization Therapy Equipment Product and Services
- 2.2.4 Boston Scientific Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Boston Scientific Recent Developments/Updates
- 2.3 Abbott
- 2.3.1 Abbott Details
- 2.3.2 Abbott Major Business
- 2.3.3 Abbott Cardiac Resynchronization Therapy Equipment Product and Services
- 2.3.4 Abbott Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Abbott Recent Developments/Updates
- 2.4 MicroPort
- 2.4.1 MicroPort Details
- 2.4.2 MicroPort Major Business
- 2.4.3 MicroPort Cardiac Resynchronization Therapy Equipment Product and Services
- 2.4.4 MicroPort Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 MicroPort Recent Developments/Updates
- 2.5 Biotronik
- 2.5.1 Biotronik Details
- 2.5.2 Biotronik Major Business
- 2.5.3 Biotronik Cardiac Resynchronization Therapy Equipment Product and Services
- 2.5.4 Biotronik Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Biotronik Recent Developments/Updates
- 2.6 Livanova
- 2.6.1 Livanova Details
- 2.6.2 Livanova Major Business
- 2.6.3 Livanova Cardiac Resynchronization Therapy Equipment Product and Services
- 2.6.4 Livanova Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Livanova Recent Developments/Updates
- 2.7 Lepu Medical
- 2.7.1 Lepu Medical Details
- 2.7.2 Lepu Medical Major Business
- 2.7.3 Lepu Medical Cardiac Resynchronization Therapy Equipment Product and Services
- 2.7.4 Lepu Medical Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Lepu Medical Recent Developments/Updates
- 2.8 Nihon Kohden
- 2.8.1 Nihon Kohden Details
- 2.8.2 Nihon Kohden Major Business
- 2.8.3 Nihon Kohden Cardiac Resynchronization Therapy Equipment Product and Services
- 2.8.4 Nihon Kohden Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Nihon Kohden Recent Developments/Updates
- 2.9 Pacetronix
- 2.9.1 Pacetronix Details
- 2.9.2 Pacetronix Major Business
- 2.9.3 Pacetronix Cardiac Resynchronization Therapy Equipment Product and Services
- 2.9.4 Pacetronix Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Pacetronix Recent Developments/Updates
- 2.10 Asahi Kasei
- 2.10.1 Asahi Kasei Details
- 2.10.2 Asahi Kasei Major Business
- 2.10.3 Asahi Kasei Cardiac Resynchronization Therapy Equipment Product and Services
- 2.10.4 Asahi Kasei Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Asahi Kasei Recent Developments/Updates
- 2.11 St. Jude Medical
- 2.11.1 St. Jude Medical Details
- 2.11.2 St. Jude Medical Major Business
- 2.11.3 St. Jude Medical Cardiac Resynchronization Therapy Equipment Product and Services
- 2.11.4 St. Jude Medical Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.11.5 St. Jude Medical Recent Developments/Updates
- 2.12 Sorin Group
- 2.12.1 Sorin Group Details
- 2.12.2 Sorin Group Major Business
- 2.12.3 Sorin Group Cardiac Resynchronization Therapy Equipment Product and Services
- 2.12.4 Sorin Group Cardiac Resynchronization Therapy Equipment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.12.5 Sorin Group Recent Developments/Updates
- 3 Competitive Environment: Cardiac Resynchronization Therapy Equipment by Manufacturer
- 3.1 Global Cardiac Resynchronization Therapy Equipment Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Cardiac Resynchronization Therapy Equipment Revenue by Manufacturer (2020-2025)
- 3.3 Global Cardiac Resynchronization Therapy Equipment Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Cardiac Resynchronization Therapy Equipment by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Cardiac Resynchronization Therapy Equipment Manufacturer Market Share in 2024
- 3.4.3 Top 6 Cardiac Resynchronization Therapy Equipment Manufacturer Market Share in 2024
- 3.5 Cardiac Resynchronization Therapy Equipment Market: Overall Company Footprint Analysis
- 3.5.1 Cardiac Resynchronization Therapy Equipment Market: Region Footprint
- 3.5.2 Cardiac Resynchronization Therapy Equipment Market: Company Product Type Footprint
- 3.5.3 Cardiac Resynchronization Therapy Equipment Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Cardiac Resynchronization Therapy Equipment Market Size by Region
- 4.1.1 Global Cardiac Resynchronization Therapy Equipment Sales Quantity by Region (2020-2031)
- 4.1.2 Global Cardiac Resynchronization Therapy Equipment Consumption Value by Region (2020-2031)
- 4.1.3 Global Cardiac Resynchronization Therapy Equipment Average Price by Region (2020-2031)
- 4.2 North America Cardiac Resynchronization Therapy Equipment Consumption Value (2020-2031)
- 4.3 Europe Cardiac Resynchronization Therapy Equipment Consumption Value (2020-2031)
- 4.4 Asia-Pacific Cardiac Resynchronization Therapy Equipment Consumption Value (2020-2031)
- 4.5 South America Cardiac Resynchronization Therapy Equipment Consumption Value (2020-2031)
- 4.6 Middle East & Africa Cardiac Resynchronization Therapy Equipment Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Cardiac Resynchronization Therapy Equipment Sales Quantity by Type (2020-2031)
- 5.2 Global Cardiac Resynchronization Therapy Equipment Consumption Value by Type (2020-2031)
- 5.3 Global Cardiac Resynchronization Therapy Equipment Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Cardiac Resynchronization Therapy Equipment Sales Quantity by Application (2020-2031)
- 6.2 Global Cardiac Resynchronization Therapy Equipment Consumption Value by Application (2020-2031)
- 6.3 Global Cardiac Resynchronization Therapy Equipment Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Cardiac Resynchronization Therapy Equipment Sales Quantity by Type (2020-2031)
- 7.2 North America Cardiac Resynchronization Therapy Equipment Sales Quantity by Application (2020-2031)
- 7.3 North America Cardiac Resynchronization Therapy Equipment Market Size by Country
- 7.3.1 North America Cardiac Resynchronization Therapy Equipment Sales Quantity by Country (2020-2031)
- 7.3.2 North America Cardiac Resynchronization Therapy Equipment Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Cardiac Resynchronization Therapy Equipment Sales Quantity by Type (2020-2031)
- 8.2 Europe Cardiac Resynchronization Therapy Equipment Sales Quantity by Application (2020-2031)
- 8.3 Europe Cardiac Resynchronization Therapy Equipment Market Size by Country
- 8.3.1 Europe Cardiac Resynchronization Therapy Equipment Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Cardiac Resynchronization Therapy Equipment Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Cardiac Resynchronization Therapy Equipment Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Cardiac Resynchronization Therapy Equipment Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Cardiac Resynchronization Therapy Equipment Market Size by Region
- 9.3.1 Asia-Pacific Cardiac Resynchronization Therapy Equipment Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Cardiac Resynchronization Therapy Equipment Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Cardiac Resynchronization Therapy Equipment Sales Quantity by Type (2020-2031)
- 10.2 South America Cardiac Resynchronization Therapy Equipment Sales Quantity by Application (2020-2031)
- 10.3 South America Cardiac Resynchronization Therapy Equipment Market Size by Country
- 10.3.1 South America Cardiac Resynchronization Therapy Equipment Sales Quantity by Country (2020-2031)
- 10.3.2 South America Cardiac Resynchronization Therapy Equipment Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Cardiac Resynchronization Therapy Equipment Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Cardiac Resynchronization Therapy Equipment Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Cardiac Resynchronization Therapy Equipment Market Size by Country
- 11.3.1 Middle East & Africa Cardiac Resynchronization Therapy Equipment Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Cardiac Resynchronization Therapy Equipment Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Cardiac Resynchronization Therapy Equipment Market Drivers
- 12.2 Cardiac Resynchronization Therapy Equipment Market Restraints
- 12.3 Cardiac Resynchronization Therapy Equipment Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Cardiac Resynchronization Therapy Equipment and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Cardiac Resynchronization Therapy Equipment
- 13.3 Cardiac Resynchronization Therapy Equipment Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Cardiac Resynchronization Therapy Equipment Typical Distributors
- 14.3 Cardiac Resynchronization Therapy Equipment Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook